Welcome to our dedicated page for Jefferson Capital SEC filings (Ticker: JCAP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Jefferson Capital, Inc. (NASDAQ: JCAP) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its activities as an analytically driven purchaser and manager of charged-off, insolvency and active consumer accounts. These SEC filings cover its operations in the United States, Canada, the United Kingdom and Latin America, and describe its work with secured and unsecured consumer receivables originated by banks, non-bank consumer lenders, auto finance companies, utilities, telecommunications providers, credit card issuers and fintech origination platforms.
On this page, you can review Jefferson Capital’s current reports on Form 8-K, which disclose material events such as quarterly financial results, asset purchase agreements and amendments to its senior secured revolving credit facility. For example, Form 8-K filings describe the asset purchase agreement to acquire a credit card receivables portfolio from affiliates of Bluestem Brands and the amendment that increased aggregate commitments and extended the maturity of the company’s revolving credit facility.
In addition to 8-Ks, Jefferson Capital’s registration statements, such as Form S-1, and periodic reports on Form 10-Q and other filings discuss risk factors, leverage, liquidity, capital resources and non-GAAP financial measures used by management. These documents explain how the company funds portfolio purchases, manages its credit facility covenants and evaluates collections and estimated remaining collections on its receivables portfolios.
Stock Titan’s SEC filings page for JCAP provides real-time access to new filings as they are posted to EDGAR, along with AI-powered summaries that highlight key points from lengthy documents. Users can quickly identify disclosures on portfolio acquisitions, financing arrangements, quarterly and annual results, and other regulatory information relevant to Jefferson Capital’s receivables management business.
Jefferson Capital, Inc. (JCAP) received an initial Form 3 disclosing that JCF IV JCAP Holding L.P. indirectly holds 43,721,808 shares of the issuer's common stock following an internal reorganization on 08/22/2025. The filing states that J.C. Flowers IV L.P. contributed 13,492,856 shares and JCF IV Coinvest JCAP L.P. contributed 30,228,952 shares to JCF IV JCAP Holding L.P. for no consideration.
The shares held by the holding entity are subject to a lock-up agreement with the underwriters from the issuer's recent IPO. JCF IV JCAP Holding GP LLC is the general partner of the holding limited partnership, and J. Christopher Flowers is identified as the ultimate controller of the related entities. The reporting persons disclaim beneficial ownership except to the extent of pecuniary interest.
J.C. Flowers IV L.P. and JCF IV Coinvest JCAP L.P. reported that on August 22, 2025 they contributed 13,492,856 and 30,228,952 shares of Jefferson Capital, Inc. (JCAP) common stock, respectively, to JCF IV JCAP Holding L.P. for no consideration as part of an internal reorganization. The contributed shares are subject to an underwriter lock-up tied to the issuer's recent initial public offering. The reporting persons state the reorganization involved no purchase or sale for value and file this Form 4 to show they are no longer beneficial owners of the reported shares. Affiliates of JCF IV JCAP Holding L.P. will separately file a Form 3.
Jefferson Capital, Inc. reported results and disclosures for the quarter ended June 30, 2025, highlighting portfolio acquisitions, funding commitments and governance structure. The company completed an IPO at $15.00 per share and had 58,266,307 shares issued and outstanding as of June 30, 2025, with IPO investors owning 17.8% and the JCF Stockholders retaining 67.6% of outstanding common stock. Jefferson purchased large receivable portfolios (face value $4,517.0 million) for $300.5 million (6.7% of face), and completed the Conn's Portfolio Purchase funded with $244.9 million in cash, which generated $54.7 million of portfolio revenue, $6.8 million of servicing revenue and $42.8 million of net operating income related to the portfolio during the period. The company reported strong collection performance, established a non-credit discount of $89.3 million at purchase, accrued an $8.6 million Canaccede Exit Incentive Payment liability, and disclosed significant leverage and multiple debt facilities including 6.000% notes due 2026 and 9.500% notes due 2029.
Jefferson Capital, Inc. filed a current report to note that it has announced its financial results for the quarter ended June 30, 2025. The company released these quarterly results through a press release dated August 14, 2025, which is furnished as Exhibit 99.1 to the report.
The information provided under Item 2.02, including Exhibit 99.1, is being treated as furnished rather than filed, meaning it is not subject to certain liability provisions of the securities laws and is not automatically incorporated into other Securities Act or Exchange Act filings unless specifically referenced.
Jefferson Capital, Inc. (JCAP) – Form 4 insider transaction filed 07/01/2025.
Investment vehicles managed by J.C. Flowers & Co. – principally J.C. Flowers IV L.P. and JCF IV Coinvest JCAP L.P. – each a 10 % beneficial owner of JCAP, reported open-market sales on 06/27/2025 of a combined 8,708,911 common shares at $15.00 per share, an aggregate value of roughly $131 million.
- J.C. Flowers IV L.P. sold 2,687,631 shares and now holds 13,492,856 shares indirectly.
- JCF IV Coinvest JCAP L.P. sold 6,021,280 shares and now holds 30,228,952 shares indirectly.
The filing re-states the ownership chain: both funds are controlled by JCF Associates IV L.P., whose general partner is JCF Associates IV Ltd., ultimately controlled by founder J. Christopher Flowers. The groups disclaim beneficial ownership except for their pecuniary interest.
Investment take-away: A large holder reduced its stake by roughly 22 % (8.7 M shares) but still retains ~43.7 M shares. While no reason for the sale is provided, the scale and timing may signal profit-taking or portfolio rebalancing, potentially adding selling pressure and raising questions about future ownership intentions.